AnswersUs

Context The user is curious about why people still die from diseases despite having antibodies, which are considered a crucial part of the immune system's defense. They are trying to understand how pathogens can overcome the effects of antibodies, and why some pathogens remain susceptible while others don't. The user specifies they want to learn more about antibody function, and not antibiotic resistance. Simple Answer Antibodies aren't always enough to completely stop a disease. Some diseases change faster than our bodies can make the right antibodies. The amount of antibodies might not be high enough to fight off the infection. Sometimes, the disease damages the body too much before the antibodies can help. Some pathogens hide inside cells where antibodies can't reach them. Detailed Answer Antibodies are indeed a crucial component of the adaptive immune system, acting as highly specific targeting mechanisms. They bind to antigens, which are unique molecules found on t...

Context This question explores the specificity of human antibodies and their ability to cross-react with similar, but not identical, pathogens. It investigates whether antibodies developed against one illness can provide any benefit or serve as a blueprint for fighting off a closely related disease, or if the immune system must start from scratch with each new, albeit similar, threat. It also touches upon the adaptive immune response and the body's ability to modify existing antibodies when faced with previously encountered illnesses, and if that adaptation extends to similar, but distinct, pathogens. Simple Answer Antibodies are super specific, like a lock and key. Each illness needs its own special antibody. Similar illnesses might have slightly different keys. Your body usually needs to make new antibodies for each new illness. Sometimes, a similar antibody might offer a tiny head start. Detailed Answer Antibodies are highly specific proteins produced by the immune system to rec...

Context The immune system's ability to produce antibodies that specifically target and neutralize antigens is a complex process. This question explores the mechanism by which immune cells determine if a produced antibody is effective. It delves into the confirmation process of successful antigen binding and neutralization, as well as what happens when an antibody binds but fails to neutralize the antigen. The core issue is understanding how immune cells differentiate between antibodies that simply recognize an antigen and those that effectively inactivate it. Simple Answer Immune cells have receptors that check if an antibody has attached to an antigen. If the antibody is attached, it signals the cell that it has found a match. The immune cell then makes more of that successful antibody. Sometimes, an antibody might attach but not stop the antigen. This is like a lock and key that fits but doesn't unlock. The immune system keeps trying until it finds an antibody that both att...

Context I was due for pneumovax today and as I left the clinic I realized "hey...wait a minute, isn't pneumonia also a bacterial thing?" before I could ask. Any way I tried reading the wikipedia entry on it and it does indeed safeguard against bacterial strains responsible for pneumonia. I'm not getting any explanation anywhere close to the simplicity of understanding viral vaccines (inactivated and live attenuated) when reading about it. Was just curious, thanks. Simple Answer Pneumovax is a type of vaccine called a 'conjugate vaccine' that works by training your immune system to recognize and fight specific bacteria. It contains parts of the bacteria called 'polysaccharide capsules' that are like little coats on the outside of the bacteria. These capsules are what the bacteria use to trick your body into thinking they're not harmful. When you get the vaccine, your immune system learns to recognize these capsules and make antibodies that can attac...

Context This question explores the challenge of developing an HIV vaccine due to the virus's high mutation rate and investigates how HIV testing works despite the variability in viral antigens. It inquires about the potential for undetectable HIV strains due to antibody differences caused by mutations. Simple Answer HIV testing looks for antibodies, not the virus itself. Antibodies are proteins your body makes to fight off infections. These antibodies are specific to certain parts of the virus, called antigens. While HIV mutates, the key antigens it uses to infect cells generally stay the same. This means tests can detect antibodies against these unchanging parts of the virus. Detailed Answer HIV testing, unlike a vaccine, does not aim to directly prevent infection. Instead, it focuses on detecting the presence of antibodies produced by the body's immune system in response to the HIV virus. These antibodies are specific to certain parts of the virus, known as antigens, and thei...

Context The question focuses on the apparent contradiction between type O blood being universally accepted as a donor due to the absence of antigens on its red blood cells and the presence of anti-A and anti-B antibodies in type O plasma. It asks why these antibodies don't cause a reaction in recipients who are not type O when receiving type O whole blood, especially considering the severe reaction a type O individual would experience if given blood of other types. Simple Answer Type O blood doesn't have A or B antigens on its red blood cells, so it won't trigger an immune response in anyone, making it universally acceptable as a donor. Type O plasma contains antibodies against A and B antigens, but these antibodies are present in a very small amount. When you give only the red blood cells (packed red blood cells), you are essentially giving only the blood cells without the plasma, hence no antibodies are given. The antibodies in type O plasma are diluted in the recipient...